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INTRODUCTION:  Metastases  to the parathyroid  gland are  very  uncommon.  Although  renal  cell carcinoma
metastasis  to the head  and  neck  region  is  well  recognised,  with  a predilection  for  unpredictable  metastasis
to unusual  sites such  as  the  thyroid  gland,  nose,  paranasal  sinuses,  and  cranial  bones,  there  are  no  reports
of parathyroid  gland  involvement.
PRESENTATION  OF  CASE:  We  describe  an  unusual  case  of  renal  cell  carcinoma  metastasis  to  a  parathyroid
gland  in a 69-year-old  male  who  had  been  treated  8 years  previously  for  a  pT3b  N0 M1  clear  cell carcinoma
of  the  right  kidney  with  a right  nephrectomy,  and  interferon  immunotherapy  for  18 months.  The patient
had  originally  presented  to the plastic  surgeons  with  a rapidly  enlarging  3  cm  superﬁcial  lesion  on  the
ventral  aspect  of  the left  forearm,  which  was excised  with  histology  revealing  metastatic  renal  (clear)
cell  carcinoma.
DISCUSSION:  Renal  cell  carcinoma  has  a reputation  for unpredictable  patterns  of metastasis,  and  our  case
highlights  this,  with  the  ﬁrst  description  in  the  literature  of  parathyroid  gland  metastasis.  Despite  the
poor  prognosis  associated  with  metastatic  renal cell carcinoma,  our patient  is still  alive 10  years  following
original  presentation,  despite  having  metastasis  to two different  extra-renal  sites  and a shortened  course
of initial  adjuvant  systemic  therapy.
CONCLUSION:  In  parathyroid  gland  metastasis,  metastectomy  can  offer  excellent  local  long term  local
control.
© 2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Renal cell carcinoma (RCC) is the most common malignant neo-
lasm affecting the kidney, accounting for 3% of adult cancers.1
pproximately 30% of patients present with metastatic disease,2
ften as the initial manifestation of RCC.
The most common sites of distant RCC metastasis are the lungs
60%), bone (40%), and liver (40%),3 but RCC is also renowned
or unpredictable patterns of secondary spread to involve almost
very other body site. Late recurrences are another feature, with
esions appearing 10 years or more following surgical treatment.4
etastatic RCC (mRCC) has a poor prognosis with a median survival
f less than 12 months.3 RCC metastasis to the head and neck region
s well recognised, occurring in approximately 15% of cases.5,6 Of
nterest, there are no reported cases of metastasis to the parathy-
oid gland. We  describe a case of RCC metastasis to the parathyroid
land with a review of the relevant literature.
∗ Corresponding author. Tel.: +44 207 723 3281; fax: +44 203 311 1234.
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210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Presentation of case
A 69-year-old male patient was referred to the head and neck
surgery department following serial computed tomography (CT)
scans of the chest that revealed an enlarging right upper mediasti-
nal mass.
He was  seen by the plastic surgeons 8 years previously with a
rapidly enlarging 3 cm superﬁcial lesion on the ventral aspect of the
left forearm which revealed metastatic renal (clear) cell carcinoma
on excision biopsy. He was subsequently treated for a pT3b N0 M1
clear cell carcinoma of the right kidney with a right nephrectomy,
and interferon immunotherapy for 18 months. He was  disease free
for 7 years post treatment. A surveillance CT scan then detected a
1.1 cm enhancing upper mediastinum mass, suggestive of a ‘lymph
node’ in the right cervical para-oesophageal region (Fig. 1). A repeat
CT scan of the chest and abdomen 12 months later showed that the
right para-oesophageal mass had increased in size to 1.4 cm,  with
no other lesions evident. The patient was  otherwise asymptomatic,
and apart from hypertension, had no other signiﬁcant past medi-
cal history. Clinical examination of the head and neck region was
unremarkable.
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 3. (a and b) Immunohistochemistry showing that only the rim of normalig. 1. Computed tomography (CT) scan of the chest showing a 1.4 cm right upper
ediastinum mass in the cervical para-oesophageal region (white arrow).
Given the suspected diagnosis of mRCC the patient was
ounselled for excision surgery via a transcervical approach. Intra-
peratively, the right thyroid lobe was mobilised medially, and
he metastatic deposit was found to lie deep to the inferior thy-
oid artery in the tracheo-oesophageal groove. The right recurrent
aryngeal nerve was in an abnormal position, having been displaced
y tumour. The tumour was excised entirely. The patient had an
neventful recovery, and was discharged on the 2nd post-operative
ay.
Histopathological assessment of the lesion, revealed a
 cm × 1.5 cm × 0.5 cm ﬁrm grey soft tissue nodule. On micro-
copic examination, it comprised a nodule of highly vascular
arcinoma comprising small lobules, cysts and clusters of cells
ith clear to eosinophilic cytoplasm, mildly pleomorphic nuclei
nd small prominent nucleoli with insigniﬁcant mitotic activity
Fig. 2). Intratumour haemorrhage and cysts were present. In this
entral zone the tumour cells co-expressed cytokeratin (AE1/3)
nd vimentin, and were positive for CD10. Around the periphery
here was an almost complete rim of compressed parathyroid
land consisting of normal parathyroid chief and oxyphilic cells. In
ome areas these formed recognisable parathyroid gland with fat,
ut in other areas the thin rim of partly clear cells was highlighted
ig. 2. Metastatic renal cell carcinoma (upper left) surrounded by parathyroid chief
nd oxyphilic cells (lower right). The neoplastic cells are polygonal with clear to
osinophilic cytoplasm, mildly pleomorphic nuclei and small prominent nucleoli
haematoxylin and eosin).parathyroid gland surrounding the metastasis was positive for chromogranin (low
power of whole lesion) and parathormone (PTH, high power).
by positive immunoreaction for parathyroid hormone (PTH) and
chromogranin (Fig. 3), which were negative in the central zone.
There was no vimentin co-expression or CD10 in the parathyroid
component. The excision margin ran along the edge of both
the parathyroid gland and in places of the carcinoma, with no
evidence of transected tumour. Overall, the histological analysis
was consistent with mRCC to the parathyroid gland.
The patient remains alive at 19 months following excision.
His post-operative PTH and corrected calcium was within normal
limits.
3. Discussion
RCC is the third most common infraclavicular tumour to metas-
tasise to the head and neck region after breast and lung cancer.7–10
The therapeutic modality for mRCC depends on the head and neck
subsite involved, but most efforts are directed at palliation to con-
trol symptoms, with metastectomy most often advocated.10–15
Metastectomy in cases of RCC metastases can be curative or at least
offer excellent long term local control. This case demonstrates that
in selected cases of RCC metastases to the head and neck region,
metastectomy can be advocated to achieve excellent local control
and potential cure.Radiotherapy has also been purported to be an effective
palliative treatment for RCC with excellent local symptom
control.11 Other treatments include cytotoxic chemotherapy,3
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mmunotherapy,2,3 and more recently molecular targeted
herapy,16 all with limited response rates.
To the best of our knowledge, mRCC to the parathyroid gland
s extremely rare, if reported. In our patient, the previous history
f mRCC made us consider RCC metastasis. However, given the
iscrete anatomical location, separate from the thyroid gland, our
nitial diagnosis was of a metastatic lymph node deposit. Intra-
perative ﬁndings of a vascular lesion closely related to the inferior
hyroid artery and recurrent laryngeal nerve did raise suspicion of
 metastatic inferior parathyroid tumour, which was  conﬁrmed on
ubsequent histological analysis.
Metastases to the parathyroid glands are extremely rare with
ery few cases in the literature, even in the context of widespread
arcinomatosis.17 A study investigating sites of metastasis in 1000
utopsies of cancer patients in 1950 did not observe a single case
f parathyroid metastasis, despite noting metastases in unusual
ocations.18 Further work from a prospective post-mortem study of
60 patients with a range of malignant neoplasms, demonstrated
etastatic involvement of at least one parathyroid gland in 19.9% of
ases.19 However, the same investigators in a retrospective study of
50 necropsies identiﬁed secondary malignant involvement of the
arathyroid in only 5.3% of cases. The most common primary sites
n decreasing order of frequency were breast, blood (leukaemia),
kin (malignant melanoma), lung, soft tissue (spindle cell sarco-
as), and lymphomas.19 Interestingly, in both series, secondary
eoplastic involvement of the parathyroid was part of widespread
etastasis, however, it should be noted that the methods employed
o identify the primary tumour site appear ambiguous, and their
esults need to be interpreted with caution. A further post-mortem
nvestigation of metastasis to endocrine glands detected only 3
ases out of 1900 patients with involvement of the parathyroid
land,20 and like the previous studies mentioned, none of the pri-
ary sites of origin included the kidney.
Despite the rich vascular supply of the parathyroid glands, it
ould appear that there is no predilection for mRCC. There was
o clinical evidence of altered calcium balance in our case preop-
ratively and post-operative calcium and PTH levels were normal.
ith the involvement of one parathyroid gland, there is nothing in
he literature to guide management of the remaining parathyroids
ith regards to close monitoring for further metastatic deposits
ersus prophylactic parathyroidectomy to prevent the develop-
ent of further metastatic deposits. Given the bizarre presentation
f mRCC in our case, the patient is being followed up closely, with
 view to localised treatment of any further metastatic deposits as
nd when they arise, depending on his symptoms and performance
tatus.
. Conclusion
RCC has a reputation for unpredictable patterns of metastasis,
nd our case highlights this, with the ﬁrst description in the lit-
rature of RCC metastasis to the parathyroid gland. Our patient
resented initially with a cutaneous RCC metastasis that upon
urther investigation resulted in detection of the right kidney
rimary. Despite the poor prognosis associated with mRCC, our
atient is still alive 10 years following original presentation, despite
aving metastasis to two different extra-renal sites and a short-
ned course of initial adjuvant systemic therapy. In mRCC to the
arathyroid gland, metastectomy can offer excellent long term local
ontrol.
1
2
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
ery Case Reports 5 (2014) 378–380
Conﬂict of interest
None declared.
Funding
None declared.
Ethical approval
Written informed consent was  obtained from the patient for
publication of this case report and case series and accompanying
images. A copy of the written consent is available for review by the
Editor-in-Chief of this journal on request
Author contributions
All authors (Enyinnaya Ofo, Rishi Mandavia, Jean-Pierre Jean-
non, Edward Odell and Ricard Simo) contributed to the case data
collection, analysis and writing of this paper.
References
1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. CA
Cancer J Clin 2006;56:106–30.
2. Lam JS, Leppert JT, Belldegrun AS, Figlin RA. Novel approaches in the therapy of
metastatic renal cell carcinoma. World J Urol 2005;23:202–12.
3. Gupta K, Miller JD, Li JZ, Russell MW,  Charbonneau C. Epidemiologic and socio-
economic burden of metastatic renal cell carcinoma (mRCC): a literature review.
Cancer Treat Rev 2008;34:193–205.
4. Sountoulides P, Metaxa L, Cindolo L. Atypical presentations and rare metastatic
sites of renal cell carcinoma: a review of case reports. J Med  Case Rep 2011;5:429.
5. Pritchyk KM,  Schiff BA, Newkirk KA, Krowiak E, Deeb ZE. Metastatic renal cell
carcinoma to the head and neck. Laryngoscope 2002;112:1598–602.
6. Miyamoto R, Helmus C. Hypernephroma metastatic to the head and neck. Laryn-
goscope 1973;83:898–905.
7. Boles R, Cerny J. Head and neck metastases from renal carcinomas. Mich Med
1971;70:616–8.
8. Nakhjavani MK, Gharib H, Goellner JR, van Heerden JA. Metastasis to the thyroid
gland. A report of 43 cases. Cancer 1997;79:574–8.
9. Di Stasi V, D’Antonio A, Caleo A, Valvano L. Metastatic renal cell carcinoma
to  the thyroid gland 24 years after the primary tumour. BMJ  Case Rep 2013,
http://dx.doi.org/10.1136/bcr-2012-007569 (in press).
0. Bugalho MJ, Mendonca E, Costa P, Santos J, Silva E, Cantarino A, et al. A multin-
odular goiter as the initial presentation of a renal cell carcinoma harbouring a
novel VHL mutation. BMC  Endocr Disord 2006;6:6.
1. Simo R, Sykes AJ, Hargreaves SP, Axon P, Birzgalis A, Slevin N, et al.
Metastatic renal cell carcinoma to the nose and paranasal sinuses. Head Neck
2000;22:722–7.
2. Lee HM, Kang HJ, Lee SH. Metastatic renal cell carcinoma presenting as epistaxis.
Eur Arch Otorhinolaryngol 2005;26:69–71.
3. Azam F, Abubakerr M,  Gollins S. Tongue metastasis as an initial presentation
of  renal cell carcinoma: a case report and literature review. J Med  Case Rep
2008;2:249.
4. Mrena R, Leivo I, Passador-Santos F, Hagstrom J, Makitie AA. Histopatholog-
ical ﬁndings in parotid gland metastases from renal cell carcinoma. Eur Arch
Otorhinolaryngol 2008;265:1005–9.
5. Sabatini P, Ducic Y. Bilateral lacrimal gland masses: unusual case of metastatic
renal cell carcinoma. J Otolaryngol Head Neck Surg 2009;38:E1–2.
6. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD,  Bukowski RM, Rixe O,  et al.
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med
2007;356:115–24.
7. Gattuso P, Khan NA, Jablokow VR, Kathuria S. Neoplasms metastatic to parathy-
roid glands. South Med  J 1988;81:1467.
8. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000
autopsied cases. Cancer 1950;3:74–85.
9. Horwitz CA, Myers WP,  Foote Jr FW.  Secondary malignant tumors of the parathy-
roid glands. Report of two cases with associated hypoparathyroidism. Am J Med
1972;52:797–808.
0. Rivadeneyra J, Lira-Puerto V, Aguilar-Parada E. Metastasis to the endocrine
glands (review of 1900 autopsies). Ginecol Obstet Mex  1972;31:139–50.uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
